Bando Chemical Industries, Ltd.

TSE:5195.T

1795 (JPY) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 108,278103,60893,74481,37190,24790,79891,26388,38793,27295,39593,43485,77186,37284,81173,59387,45398,66295,20084,25776,958
Cost of Revenue 77,24674,18666,08156,52063,18163,27263,73161,59666,09669,99668,71063,31063,13261,09253,65965,58270,68867,88760,90753,545
Gross Profit 31,03229,42227,66324,85127,06627,52627,53226,79127,17625,39924,72422,46123,24023,71919,93421,87127,97427,31323,35023,413
Gross Profit Ratio 0.2870.2840.2950.3050.30.3030.3020.3030.2910.2660.2650.2620.2690.280.2710.250.2840.2870.2770.304
Reseach & Development Expenses 4,1964,1104,0294,0944,4214,4594,3754,2984,2441,2041,1421,10900000000
General & Administrative Expenses 23,44722,68721,78219,91221,81320,83717,28817,44817,54018,13117,00516,40200000000
Selling & Marketing Expenses 0000002,3972,3242,4842,4702,2011,96400000000
SG&A 23,44722,68721,78219,91221,81320,83719,68519,77220,02420,60119,20618,36600000000
Other Expenses 004,239833,87828317318128216531-68-1498109426107239409601
Operating Expenses 23,44722,61026,02119,99525,69121,12021,19620,89521,21420,60119,20618,36618,66918,66217,48319,75620,64819,28518,29317,652
Operating Income 7,5858,2592,6655,3772,0567,1566,3365,8965,9604,7975,5174,0944,5705,0562,4502,1157,3258,0285,0575,760
Operating Income Ratio 0.070.080.0280.0660.0230.0790.0690.0670.0640.050.0590.0480.0530.060.0330.0240.0740.0840.060.075
Total Other Income Expenses Net -3771,679-2,578609-2,68784377657125522619-554-1,802-147-363-1,545243-759943-148
Income Before Tax 7,2088,5423,4145,6182,0956,8996,4136,5536,0865,3206,1363,5402,7694,9102,0885707,5697,2696,0005,613
Income Before Tax Ratio 0.0670.0820.0360.0690.0230.0760.070.0740.0650.0560.0660.0410.0320.0580.0280.0070.0770.0760.0710.073
Income Tax Expense 2,4582,7802,1971,6601,3941,7631,5821,5731,6281,4701,7659821,2861,5188157372,1623,1602,3591,537
Net Income 6,1805,7221,2113,9436825,1004,7954,9514,3863,7584,2802,5101,4403,3331,234-2555,2893,9853,7134,086
Net Income Ratio 0.0570.0550.0130.0480.0080.0560.0530.0560.0470.0390.0460.0290.0170.0390.017-0.0030.0540.0420.0440.053
EPS 142.55129.9626.9186.5614.91111.3104.72107.993.3179.990.9852.9429.6867.4824.62-5.08105.3678.6870.4676.48
EPS Diluted 142.55129.9626.9186.5614.91111.3104.72107.993.3179.990.9852.9429.6867.4824.62-5.08105.3678.6870.3476.28
EBITDA 13,44414,8099,43611,7358,45811,78311,30810,97511,19210,43710,6259,4839,53010,2598,4388,13214,38013,32210,69511,018
EBITDA Ratio 0.1240.1430.1010.1440.0940.130.1240.1240.120.1090.1140.1110.110.1210.1150.0930.1460.140.1270.143